UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April 19, 2017

 

 

AMN HEALTHCARE SERVICES, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

001-16753   06-1500476

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

12400 High Bluff Drive, Suite 100

San Diego, California 92130

(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: (866) 871-8519

NOT APPLICABLE

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

☐   Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐   Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐   Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Section 5 – Corporate Governance and Management

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(a) The Board of Directors of AMN Healthcare Services, Inc. (the “Company”) previously approved, subject to stockholder approval, the AMN Healthcare 2017 Equity Plan (the “Equity Plan”). The Company’s stockholders approved the Equity Plan at the Annual Meeting of Stockholders (the “Annual Meeting”). A more detailed summary of the material terms of the Equity Plan appears on pages 54 – 61 of the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on March 9, 2017 (the “2017 Proxy Statement”). The foregoing description of the Equity Plan is qualified in its entirety by reference to the full text of the Equity Plan, which is filed as Exhibit 10.1 hereto, and incorporated herein by reference.

The Board of Directors of the Company previously approved, subject to stockholder approval, the AMN Healthcare 2017 Senior Executive Incentive Bonus Plan (the “Bonus Plan”). The Company’s stockholders approved the Bonus Plan at the Annual Meeting. A more detailed summary of the material terms of the Bonus Plan appears on pages 51 – 53 of the 2017 Proxy Statement. The foregoing description of the Bonus Plan is qualified in its entirety by reference to the full text of the Bonus Plan, which is filed as Exhibit 10.2 hereto, and incorporated herein by reference.

Item 5.07. Submission of Matters to a Vote of Security Holders.

(a) On April 19, 2017, AMN Healthcare Services, Inc. (the “Company”) held its 2017 Annual Meeting of Stockholders (the “Annual Meeting”).

(b) The following items of business were voted upon by the Company’s stockholders at the Annual Meeting:

 

  1. Each of the Board of Directors’ nominees for director was elected to serve until the next Annual Meeting or until their successors are duly elected and qualified, by the vote set forth in the table immediately below:

 

Director

  

For

    

Against

    

Abstain

    

Broker Non-Votes

 

Mark G. Foletta

     40,266,138        265,752        15,998        4,365,906  

R. Jeffrey Harris

     39,663,505        869,167        15,216        4,365,906  

Michael M.E. Johns, M.D.

     39,844,115        689,410        14,363        4,365,906  

Martha H. Marsh

     39,750,208        782,785        14,895        4,365,906  

Susan R. Salka

     40,199,172        334,221        14,495        4,365,906  

Andrew M. Stern

     39,622,556        909,414        15,918        4,365,906  

Paul E. Weaver

     39,741,606        790,857        15,425        4,365,906  

Douglas D. Wheat

     39,797,846        734,485        15,557        4,365,906  

 

  2. The compensation of named executive officers was approved, on an advisory (non-binding) basis, by the vote set forth in the table immediately below:

 

For

 

Against

   

Abstain

   

Broker Non-Votes

 
38,950,567     1,289,059       308,262       4,365,906  

 

  3. The frequency of an advisory vote on executive compensation, on an advisory (non-binding) basis, was recommended every one year, by the vote set forth in the table immediately below:

 

1 Year

 

2 Years

   

3 Years

   

Abstain

 
34,720,580     49,913       5,749,419       27,976  

Based on the approval of one year as the frequency of an advisory vote on the compensation of the Company’s named executive officers, the Board of Directors has determined that it will hold an advisory vote on the compensation of the Company’s named executive officers annually until the next required vote on the frequency of such an advisory vote.

 

  4. The AMN Healthcare 2017 Senior Executive Incentive Bonus Plan was approved by the vote set forth in the table immediately below:

 

For

 

Against

   

Abstain

   

Broker Non-Votes

 
39,357,155     1,149,520       41,213       4,365,906  

  5. The AMN Healthcare 2017 Equity Plan was approved by the vote set forth in the table immediately below:

 

For

 

Against

   

Abstain

   

Broker Non-Votes

 
38,680,407     1,824,095       43,386       4,365,906  

 

  6. The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017 was ratified by the vote set forth in the table immediately below:

 

For

 

Against

   

Abstain

   

Broker Non-Votes

 
43,681,654     1,191,469       40,671       0  

Section 9 – Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

10.1    AMN Healthcare 2017 Equity Plan.
10.2    AMN Healthcare 2017 Senior Executive Incentive Bonus Plan.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    AMN Healthcare Services, Inc.
Date: April 25, 2017     By:   /s/ Susan R. Salka
      Susan R. Salka
      President & Chief Executive Officer
AMN Healthcare Services (NYSE:AMN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more AMN Healthcare Services Charts.
AMN Healthcare Services (NYSE:AMN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more AMN Healthcare Services Charts.